ERBB2 and breast cancer: Moreover, our recent documentation of differential survival outcomes in ErbB2-overexpressing breast cancers associated with different phosphorylation patterns (Ouyang et al, 1999b, 2001) supports the notion of multiple signalling pathways governing tumour growth phenotypes.